Defytime Emea
Oct 13, 20171 min read
FDA panel backs gene therapy for rare form of blindness
Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the...
7 views
top of page
bottom of page